Myringoplasty in children.
Our 11 years of experience of myringoplasty in 87 children aged 3 to 14 years were retrospectively studied. The children were followed up over a period of 3 years. Children in the 3-to-12-year-old age group had a success rate of 57.7%. Graft-take rate was 100% in children operated on at the age of 13 and 14 years. Revision surgery was needed in 33 ears, and ultimate success was achieved in 88.9%. Within the same period, 38 ears were conservatively treated and 20 perforations of them were spontaneously closed. The state of the opposite ear and the perforation size were not a decisive factor in the results of myringoplasty. Children between 7 and 10 years old with small mastoid pneumatization had a statistically lower graft-take rate. We concluded that myringoplasty is warranted for children 13 years of age and older or children aged 7 to 12 years with large mastoid pneumatization.
Nagai
M
M
Department of Otolaryngology, Miyazaki Medical College, Japan.
Nagai
T
T
Morimitsu
T
T
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005500:Follow-Up Studies; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008416:Mastoid / Q000033:anatomy & histology / Q000254:growth & development*; D009225:Myringoplasty / Q000592:standards*; D010035:Otitis Media, Suppurative / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012008:Recurrence; D012086:Reoperation / Q000706:statistics & numerical data; D012189:Retrospective Studies; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents